
PresbyLASIK offers advatages compared to inlays, according to Dr Tamayo

PresbyLASIK offers advatages compared to inlays, according to Dr Tamayo

A review of surgical results demonstrate safety

Six-month results from the GALILEO study show promise for VEGF Trap-Eye

A round-up of the latest ophthalmic products

If improvement is not seen after 24 hours vitrectomy should be considered

Loss of optical media transperency reduces accuracy in clinical practice

If initial trabeculectomy has failed, canaloplasty can be an option, according to Dr Brusini

Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.

Ranibizumab has been recommended for use within the NHS in England and Wales to treat macular oedema (ME) secondary to retinal vein occlusion (RVO).

Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.

According to recently published data, POAG patients with diabetes mellitus (DM) undergoing primary trabeculectomy with MMC do not achieve the same long-term IOP control compared to patients without DM.

Novaliq has secured €13.9 million in a fifth round of financing for a dry eye portfolio.

Intravitreal bevacizumab is not recommended for the treatment of new onset Nonarteritic Anterior Ischemic Optic Neuropathy (NAION).

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Intravitreal bevacizumab is well tolerated and causes the regression of abnormal diabetic neovascularization, according to recently published data.

A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers.

Multifocal diffractive add-on IOL is a suitable alternative to standard multifocal IOLs for sulcus fixation.

Unoprostone will begin patient enrolment for the Phase III clinical study for the treatment of retinitis pigmentosa (RP), claims the latest press release.

Undersized big-bubbles for DALK can safely be increased using blunt dissection for white-margin bubbles and ophthalmic viscosurgical device injection for clear-margin bubbles.

Low-fluence photodynamic therapy (PDT) decreases subfoveal choroidal thickness (SFCT) in central serous chorioretinopathy (CSC), states a paper in the journal Eye.

Small pupil size and short axial length predict good near vision after phacoemulsification and monofocal IOL implantation.

Trabectome, a device that ablates the arc of trabecular meshwork, is a safe and effective alternative to glaucoma surgery, according to a recent paper.

Ocular prosthesis wearers may require clinical assessment and management for meibomian gland dysfunction (MGD).

Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series.

119th Congress of SFO will be held in Paris, France


Botulinum toxin type A (BTA) injections, with or without sodium hyaluronate (SH), are effective and feasible for the treatment of infantile esotropia.

Reading test results key is method to correct presbyopia in patients with emmetropia

Oral drug fenretinide has potential for the treatment of geographic atrophy (GA), but further studies are required.

Early reports on off-label uses for anti-VEGFs are promising